Vapotherm (VAPO) Revenue & Revenue Breakdown
Vapotherm Revenue Highlights
Latest Revenue (Y)
$68.67M
Latest Revenue (Q)
$16.88M
Main Segment (Y)
Product Revenue
Main Geography (Y)
UNITED STATES
Vapotherm Revenue by Period
Vapotherm Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $68.67M | 2.80% |
2022-12-31 | $66.80M | -41.04% |
2021-12-31 | $113.29M | -9.89% |
2020-12-31 | $125.73M | 161.38% |
2019-12-31 | $48.10M | 13.51% |
2018-12-31 | $42.38M | 19.05% |
2017-12-31 | $35.60M | 18.18% |
2016-12-31 | $30.12M | - |
Vapotherm Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $16.88M | -11.76% |
2024-03-31 | $19.13M | -3.04% |
2023-12-31 | $19.73M | 30.11% |
2023-09-30 | $15.17M | -5.42% |
2023-06-30 | $16.04M | -9.55% |
2023-03-31 | $17.73M | -4.99% |
2022-12-31 | $18.66M | 37.79% |
2022-09-30 | $13.54M | 4.43% |
2022-06-30 | $12.97M | -40.01% |
2022-03-31 | $21.62M | -2.80% |
2021-12-31 | $22.24M | -41.64% |
2021-09-30 | $38.12M | 84.80% |
2021-06-30 | $20.63M | -36.16% |
2021-03-31 | $32.31M | -21.02% |
2020-12-31 | $40.91M | 33.86% |
2020-09-30 | $30.56M | -13.07% |
2020-06-30 | $35.15M | 83.90% |
2020-03-31 | $19.11M | 46.93% |
2019-12-31 | $13.01M | 20.36% |
2019-09-30 | $10.81M | -9.82% |
2019-06-30 | $11.99M | -2.54% |
2019-03-31 | $12.30M | 5.25% |
2018-12-31 | $11.69M | 24.46% |
2018-09-30 | $9.39M | -11.11% |
2018-06-30 | $10.56M | -1.64% |
2018-03-31 | $10.74M | 3.19% |
2017-12-31 | $10.41M | 32.09% |
2017-09-30 | $7.88M | -3.70% |
2017-06-30 | $8.18M | -5.47% |
2017-03-31 | $8.66M | - |
Vapotherm Revenue Breakdown
Vapotherm Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 |
---|---|
Service, Other | $5.80M |
Product Revenue | $60.50M |
Latest
Quarterly Revenue by Product
Product/Service | Mar 24 | Dec 23 | Sep 23 |
---|---|---|---|
Service, Other | $1.49M | $4.29M | $1.51M |
Product Revenue | $16.95M | $47.44M | $13.06M |
Latest
Vapotherm Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
UNITED STATES | $51.02M | $7.56M | $84.15M | $99.16M | $36.58M |
Non-US | $17.65M | $1.23M | - | - | - |
Non Us | - | - | $29.14M | $26.57M | $11.52M |
Latest
Quarterly Revenue by Country
Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UNITED STATES | $15.08M | $37.91M | $11.23M | $1.11M | $775.00K | $1.19M | $1.78M | $2.16M | $16.50M | $17.80M | $11.33M | $22.07M | $33.61M | $25.53M | $25.68M | $14.34M | $9.82M | $8.04M | $8.68M | - |
Non-US | $4.05M | $12.72M | $3.94M | $353.00K | $638.00K | $321.00K | $306.00K | $329.00K | - | - | - | - | - | - | - | - | - | - | - | - |
Non Us | - | - | - | - | - | - | - | - | $5.12M | $4.45M | $5.17M | $9.29M | $10.24M | $7.29M | $5.03M | $9.47M | $4.77M | $3.19M | $2.77M | $3.31M |
U S | - | - | - | - | - | - | - | - | - | - | $32.95M | - | - | - | - | - | - | - | - | - |
Latest
Vapotherm Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
SGHT | Sight Sciences | $81.06M | $20.16M |
NPCE | NeuroPace | $65.42M | $21.06M |
SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
RPID | Rapid Micro Biosystems | $22.52M | $7.60M |
HSCS | Heart Test Laboratories | $18.60M | - |
VVOS | Vivos Therapeutics | $13.80M | $3.86M |
TIVC | Tivic Health Systems | $1.18M | $126.00K |
NXL | Nexalin | $110.75K | $36.03K |
BJDX | Bluejay Diagnostics | - | - |
BBLG | Bone Biologics | - | - |